Uncomplicated hepatic dysfunction

Drug	Drug Name	Drug Description
DB02262	Orotic acid	A drug used to manage uncomplicated liver dysfunction in combination with xanthine.
DB09298	Silibinin	A flavonolignan with hepatoprotective effects used to treat toxic liver damage and as an adjunct in the management of chronic conditions such as cirrhosis and hepatitis.
DB02134	Xanthine	A drug used to manage uncomplicated liver dysfunction in combination with orotic acid.

Drug	Drug Name	Target	Type
DB02262	Orotic acid	Orotate phosphoribosyltransferase	target
DB02262	Orotic acid	Dihydroorotate dehydrogenase (quinone), mitochondrial	target
DB02262	Orotic acid	Dihydroorotate dehydrogenase (quinone)	target
DB02262	Orotic acid	Dihydroorotase	target
DB02262	Orotic acid	Dihydroorotate dehydrogenase A (fumarate)	target
DB09298	Silibinin	Solute carrier family 22 member 6	transporter
DB09298	Silibinin	UDP-glucuronosyltransferase 1-1	enzyme
DB09298	Silibinin	Solute carrier organic anion transporter family member 1B1	transporter
DB09298	Silibinin	Solute carrier organic anion transporter family member 1B3	transporter
DB09298	Silibinin	Solute carrier organic anion transporter family member 2B1	transporter
DB02134	Xanthine	Purine nucleoside phosphorylase 2	target
DB02134	Xanthine	Xanthine phosphoribosyltransferase	target
DB02134	Xanthine	Cytochrome P450 1A2	enzyme

Drug	Drug Name	Phase	Status	Count